Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity of Luebeck

About this trial

Prospective, observational, single center, pilot study to analyze the feasibility of motion and structural data integration in patients with ventricular arrhythmia by means of artificial intelligence for improved arrhythmogenic substrate characterization and motion management during stereotactic arrhythmia radioablation.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Indication for catheter ablation of ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, premature ventricular contractions)

Indication for preprocedural contrast-enhanced cardiac computed tomography for cardiac structure characterization

Disqualifiers

Platelet count < 100,000 cells/mm3

BMI > 45 kg/m2 or < 18 kg/m2

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

20 Participants
are grouped into 1 trial group

Sponsors and collaborators

University of Luebeck

Lead sponsor

Institute for Robotics and Cognitive Systems, University of Luebeck, Germany

Collaborator